Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Pfizer Slapped With Rs 8.79 Cr GST Demand Over Alleged ITC Irregularities, Plans Appeal

Pfizer, BioNTech get USFDA approval, authorization for Omicron KP.2 adapted COVID vaccine

Ruchika Sharma23 Aug 2024 12:30 PM IST

New York: Pfizer Inc. and BioNTech SE have announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics...

Scheme to strengthen domestic medical device industry to be rolled out in next one month: DoP Secretary

Ruchika Sharma23 Aug 2024 11:30 AM IST

New Delhi: A new scheme will be launched to bolster the domestic medical device industry within next one month, according to Department of...

Adverse drug reactions from normal saline: Punjab imposes 3-year ban on Captab Biotech

156 FDCs banned with immediate effect, declared irrational: Ministry of Health and Family Welfare

Ruchika Sharma22 Aug 2024 6:00 PM IST

New Delhi: Citing that there is no therapeutic justification for the ingredients contained in fixed dose combinations (FDC) and that the FDC may...

CDSCO Panel Clears Bristol Myers Yervoy for Two New Cancer Indications

USFDA accepts application for Opdivo plus Yervoy for unresectable hepatocellular carcinoma

Ruchika Sharma22 Aug 2024 4:30 PM IST

Princeton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental Biologics License...

DMER Releases Pharmacist, Lab Technician CBT Results 2025

Marksans Pharma subsidiary Relonchem bags marketing authorization from UK MHRA for Fluoxetine Capsules

Ruchika Sharma22 Aug 2024 3:25 PM IST

Mumbai: Marksans Pharma Limited has announced that its wholly owned subsidiary Relonchem Limited has received Marketing Authorization from...

Working on Monkeypox vaccine: Serum Institute CEO

Ruchika Sharma22 Aug 2024 1:30 PM IST

New Delhi: The Serum Institute of India has said that the Company is currently working on developing a Monkeypox vaccine to address the...

USFDA Approves Bionpharmas Generic HIV Drug Etravirine

Indoco Remedies secures USFDA nod for Lofexidine Tablets 0.18 mg

Ruchika Sharma22 Aug 2024 12:30 PM IST

Mumbai: Indoco Remedies Limited has announced the receipt of final approval from the U.S. Food and Drug Administration (USFDA) for Abbreviated...

Principal Scientific Adviser to GoI reviews progress to transform India regulatory ecosystem for medical products

Ruchika Sharma22 Aug 2024 11:30 AM IST

New Delhi: Prof. Ajay Kumar Sood, Principal Scientific Adviser (PSA) to the Government of India took a meeting to review the progress made...

Daiichi Sankyo, AstraZeneca Enhertu gets USFDA breakthrough therapy designation for certain patients with HER2 low or HER2 ultralow metastatic breast cancer

Ruchika Sharma21 Aug 2024 3:37 PM IST

Tokyo: ENHERTU (fam-trastuzumab deruxtecan-nxki) has been granted Breakthrough Therapy Designation (BTD) in the U.S. for the treatment of unresectable...

Palamur Biosciences Faces USFDA Warning for Multiple GLP Compliance Failures

JnJ chemotherapy free lung cancer treatment Rybrevant plus Lazcluze gets USFDA okay

Ruchika Sharma21 Aug 2024 12:30 PM IST

New Jersey: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved RYBREVANT (amivantamab-vmjw) plus...

NPPA Finally Allows GSK to Discontinue Grisovin FP

GSK secures USFDA Breakthrough Therapy Designation for GSK5764227 for extensive stage small cell lung cancer

Ruchika Sharma21 Aug 2024 11:30 AM IST

London: GSK plc has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for GSK5764227 (GSK’227),...

Johnson and Johnson Agrees to Cut US Drug Prices in Deal with Trump Administration to Avoid Tariffs

Johnson & Johnson to acquire V-Wave

Ruchika Sharma21 Aug 2024 10:00 AM IST

New Brunswick: Johnson & Johnson has announced that it has entered into a definitive agreement to acquire V-Wave Ltd., a privately-held...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok